NDC 51991-855

REPAGLINIDE

Repaglinide

REPAGLINIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is Repaglinide.

Product ID51991-855_5b467e3d-65a6-42d1-9b6c-0ab25fac91fc
NDC51991-855
Product TypeHuman Prescription Drug
Proprietary NameREPAGLINIDE
Generic NameRepaglinide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-05-01
Marketing CategoryANDA / ANDA
Application NumberANDA091517
Labeler NameBreckenridge Pharmaceutical, Inc.
Substance NameREPAGLINIDE
Active Ingredient Strength2 mg/1
Pharm ClassesGlinide [EPC],Potassium Channel Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51991-855-01

100 TABLET in 1 BOTTLE (51991-855-01)
Marketing Start Date2015-05-01
Marketing End Date2022-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51991-855-01 [51991085501]

REPAGLINIDE TABLET
Marketing CategoryANDA
Application NumberANDA091517
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-05-01

Drug Details

Active Ingredients

IngredientStrength
REPAGLINIDE2 mg/1

OpenFDA Data

SPL SET ID:f5904c23-fa89-4d3f-b3da-8186fba83df4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200257
  • 200256
  • 200258
  • Pharmacological Class

    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]
    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]

    Medicade Reported Pricing

    51991085501 REPAGLINIDE 2 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "REPAGLINIDE" or generic name "Repaglinide"

    NDCBrand NameGeneric Name
    0378-3122Repagliniderepaglinide
    0378-3123Repagliniderepaglinide
    0574-0240RepaglinideREPAGLINIDE
    0574-0241RepaglinideREPAGLINIDE
    0574-0242RepaglinideREPAGLINIDE
    51079-539Repagliniderepaglinide
    51991-853REPAGLINIDEREPAGLINIDE
    51991-854REPAGLINIDEREPAGLINIDE
    51991-855REPAGLINIDEREPAGLINIDE
    57237-157RepaglinideRepaglinide
    57237-158RepaglinideRepaglinide
    57237-159RepaglinideRepaglinide
    57664-745RepaglinideRepaglinide
    57664-747RepaglinideRepaglinide
    60429-484REPAGLINIDEREPAGLINIDE
    60429-485REPAGLINIDEREPAGLINIDE
    60429-486REPAGLINIDEREPAGLINIDE
    68084-967RepaglinideRepaglinide
    68084-954RepaglinideRepaglinide
    65862-670RepaglinideRepaglinide
    65862-671RepaglinideRepaglinide
    65862-672RepaglinideRepaglinide
    0169-0081Prandinrepaglinide
    0169-0082Prandinrepaglinide
    0169-0084Prandinrepaglinide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.